These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8887199)

  • 1. Increased risk from third-generation progestogens: fuzzy logic or fuzzy science?
    Corson SL
    J Reprod Med; 1996 Sep; 41(9):711-2. PubMed ID: 8887199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H; Norpoth T; Michaels MA
    Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives and venous thromboembolism: an epidemiological review.
    Lidegaard O
    Eur J Contracept Reprod Health Care; 1996; 1(1):13-20. PubMed ID: 9678133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives and venous thromboembolism.
    Paul C
    N Z Med J; 1996 Nov; 109(1033):413-5. PubMed ID: 8941290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. German court lifts OC prescription ban.
    Contracept Technol Update; 1998 Mar; 19(3):41-2. PubMed ID: 12293274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of venous thromboembolic disease and OC use.
    Ory HW
    Dialogues Contracept; 1996; 5(1):4-7, 10. PubMed ID: 12347722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and the risk of DVT.
    Piegsa K; Guillebaud J
    Practitioner; 1996 Sep; 240(1566):544-51. PubMed ID: 8984464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive pills and the risk of venous thromboembolism.
    Prog Hum Reprod Res; 1996; (39):2-3. PubMed ID: 12292198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
    Contracept Technol Update; 1997 Dec; 18(12):145-8. PubMed ID: 12348219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive risks: a realistic appraisal.
    Bressler R; Durand JL
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and venous thromboembolism: consensus conference statement.
    Dialogues in Contraception Consensus Conference (1995: Chicago)
    Dialogues Contracept; 1996; ():1-8. PubMed ID: 12320455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and thrombotic disease: risk of venous thromboembolism.
    Helmerhorst FM; Bloemenkamp KW; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1997 Jul; 78(1):327-33. PubMed ID: 9198174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
    Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
    Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The truth about oral contraceptives and venous thromboembolism.
    Shulman LP; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contraceptive agents and risk of thrombosis].
    Maurer-Major E; Keller PJ
    Praxis (Bern 1994); 1997 Oct; 86(40):1543-8. PubMed ID: 9417570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of a large-scale surveillance system in Planned Parenthood Federation of America clinics to monitor cardiovascular events in users of combination oral contraceptives.
    Burnhill MS
    Int J Fertil Womens Med; 1999; 44(1):19-30. PubMed ID: 10206196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.